These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3974822)

  • 1. Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings.
    Nosko M; Weir B; Krueger C; Cook D; Norris S; Overton T; Boisvert D
    Neurosurgery; 1985 Feb; 16(2):129-36. PubMed ID: 3974822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings.
    Espinosa F; Weir B; Overton T; Castor W; Grace M; Boisvert D
    J Neurosurg; 1984 Jun; 60(6):1167-75. PubMed ID: 6726360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
    Nosko M; Weir BK; Lunt A; Grace M; Allen P; Mielke B
    J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm.
    Krueger C; Weir B; Nosko M; Cook D; Norris S
    Neurosurgery; 1985 Feb; 16(2):137-40. PubMed ID: 3974823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings.
    Espinosa F; Weir B; Shnitka T; Overton T; Boisvert D
    J Neurosurg; 1984 Jun; 60(6):1176-85. PubMed ID: 6726361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimodipine and chronic vasospasm in monkeys: Part 3. Cardiopulmonary effects.
    Nosko M; Norris SL; Weir B; King EG; Grace M
    Neurosurgery; 1986 Mar; 18(3):261-5. PubMed ID: 3703185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
    Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
    J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm.
    Lewis PJ; Weir BK; Nosko MG; Tanabe T; Grace MG
    Neurosurgery; 1988 Mar; 22(3):492-500. PubMed ID: 3362315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW; Grolimund P; Zurbruegg HR
    Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
    Gioia AE; White RP; Bakhtian B; Robertson JT
    J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experiences with nimodipine (Bay e 9736)].
    Russegger L; Kostron H; Twerdy K; Grunert V
    Neurochirurgia (Stuttg); 1984 Mar; 27(2):39-43. PubMed ID: 6728094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report.
    Grotenhuis JA; Bettag W; Fiebach BJ; Dabir K
    J Neurosurg; 1984 Aug; 61(2):231-40. PubMed ID: 6737047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats.
    Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M
    Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H; Nosko M; Weir B
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.
    Allen GS; Ahn HS; Preziosi TJ; Battye R; Boone SC; Boone SC; Chou SN; Kelly DL; Weir BK; Crabbe RA; Lavik PJ; Rosenbloom SB; Dorsey FC; Ingram CR; Mellits DE; Bertsch LA; Boisvert DP; Hundley MB; Johnson RK; Strom JA; Transou CR
    N Engl J Med; 1983 Mar; 308(11):619-24. PubMed ID: 6338383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
    Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
    J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
    Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.